Financials
- Market Capitalization 1.78 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-63.19
Relación precio/flujo de caja
15.2
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2080 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.73 USD | -1.09% | -0.55% | +20.21% | -7.22% | 1.78 B USD | ||
| 2092 | FTRE Fortrea Holdings Inc. - Common Stock | 18.37 USD | -2.34% | +0.22% | -4.52% | +90.56% | 1.75 B USD | ||
| 2104 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.29 USD | -1.28% | -2.23% | +1.47% | +16.91% | 1.72 B USD |